sulfasalazine has been researched along with Deficiency of Glucose-6-Phosphate Dehydrogenase in 2 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BEUTLER, E | 1 |
| Cohen, SM | 1 |
| Rosenthal, DS | 1 |
| Karp, PJ | 1 |
2 other studies available for sulfasalazine and Deficiency of Glucose-6-Phosphate Dehydrogenase
| Article | Year |
|---|---|
DRUG-INDUCED BLOOD DYSCRASIAS. III. HEMOLYTIC ANEMIA.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Anemia; Anemia, Hemolytic; Black People; Drug Hypersensit | 1964 |
Ulcerative colitis and erythrocyte G6PD deficiency. Salicylazosulfapyridine-provoked hemolysis.
Topics: Adult; Anemia, Hemolytic; Colitis, Ulcerative; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; | 1968 |